Info Risk Today Podcast
Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- More information
Informações:
Synopsis
While recent draft guidance from the Food and Drug Administration on artificial intelligence-enabled medical devices is non-binding, the document signals that the agency is intensifying its regulatory scrutiny of these technologies, said Dr. Scott Schell of IT consulting firm Cognizant.
